These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8724110

  • 1. Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136-->Ser) variant in multigenerational pedigree studies.
    Pocovi M, Cenarro A, Civeira F, Myers RH, Casao E, Esteban M, Ordovas JM.
    Atherosclerosis; 1996 Apr 26; 122(1):33-46. PubMed ID: 8724110
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia.
    Feussner G, Albanese M, Mann WA, Valencia A, Schuster H.
    Eur J Clin Invest; 1996 Jan 26; 26(1):13-23. PubMed ID: 8682150
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein E2 (Arg136 --> Cys) mutation in the receptor binding domain of apoE is not associated with dominant type III hyperlipoproteinemia.
    März W, Hoffmann MM, Scharnagl H, Fisher E, Chen M, Nauck M, Feussner G, Wieland H.
    J Lipid Res; 1998 Mar 26; 39(3):658-69. PubMed ID: 9548597
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR, Brennan SO, Janus ED, Fraser R, Carrell RW.
    J Clin Invest; 1987 Aug 26; 80(2):483-90. PubMed ID: 3038959
    [Abstract] [Full Text] [Related]

  • 6. Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype.
    Feussner G, Funke H, Weng W, Assmann G, Lackner KJ, Ziegler R.
    Eur J Clin Invest; 1992 Sep 26; 22(9):599-608. PubMed ID: 1360898
    [Abstract] [Full Text] [Related]

  • 7. Variable expression of hypercholesterolemia in Apolipoprotein E2* (Arg136 --> Cys) heterozygotes.
    Hubácek JA, Pitha J, Stávek P, Schmitz G, Poledne R.
    Physiol Res; 2000 Sep 26; 49(3):307-14. PubMed ID: 11043917
    [Abstract] [Full Text] [Related]

  • 8. Compound heterozygotes for a novel mutation, apo E1 Nagoya (Arg142Ser) and Apo E2 (Arg158Cys), with severe type III hyperlipoproteinemia and familial hypercholesterolemia.
    Sakuma N, Hibino T, Saeki T, Nagata T, Sato T, Okuda N, Matsunaga A, Sasaki J.
    J Atheroscler Thromb; 2014 Sep 26; 21(9):983-8. PubMed ID: 24953047
    [Abstract] [Full Text] [Related]

  • 9. Three-dimensional structure of the LDL receptor-binding domain of the human apolipoprotein E2 (Arg136-->Cys) variant.
    Feussner G, Albanese M, Valencia A.
    Atherosclerosis; 1996 Oct 25; 126(2):177-84. PubMed ID: 8902143
    [Abstract] [Full Text] [Related]

  • 10. Genetic heterogeneity in familial dysbetalipoproteinemia. The E2(lys146----gln) variant results in a dominant mode of inheritance.
    Smit M, de Knijff P, van der Kooij-Meijs E, Groenendijk C, van den Maagdenberg AM, Gevers Leuven JA, Stalenhoef AF, Stuyt PM, Frants RR, Havekes LM.
    J Lipid Res; 1990 Jan 25; 31(1):45-53. PubMed ID: 2313204
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein E2(Arg158----Cys) frequency in a hyperlipidemic French-Canadian population of apolipoprotein E2/2 subjects. Determination by synthetic oligonucleotide probes.
    Weisgraber KH, Newhouse YM, Taylor JM, Tuan B, Nestruck AC, Davignon J, Mahley RW.
    Arteriosclerosis; 1989 Jan 25; 9(1):50-7. PubMed ID: 2912421
    [Abstract] [Full Text] [Related]

  • 12. Familial dysbetalipoproteinemia in three patients with apoE 2*(Arg136-->Cys) gene variant.
    Vrablík M, Horínek A, Ceska R, Stulc T, Kvasnicka T.
    Physiol Res; 2003 Jan 25; 52(5):647-50. PubMed ID: 14535841
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of an apolipoprotein(e) variant associated with type III hyperlipoproteinaemia in an indigenous Australian.
    Tate JR, Hoffmann MM, Lovelock PK, Kesting JB, Shaw JT.
    Ann Clin Biochem; 2001 Jan 25; 38(Pt 1):46-53. PubMed ID: 11270841
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein E1 Lys-146----Glu with type III hyperlipoproteinemia.
    Moriyama K, Sasaki J, Matsunaga A, Arakawa F, Takada Y, Araki K, Kaneko S, Arakawa K.
    Biochim Biophys Acta; 1992 Sep 22; 1128(1):58-64. PubMed ID: 1356443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L, de Wit E, Leuven JG, Klasen E, Utermann G, Weber W, Beisiegel U.
    Hum Genet; 1986 Jun 22; 73(2):157-63. PubMed ID: 3721502
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.